Evidence map›Paper›PMID 31347695›Full record

ArticleJournal of anatomy2019

Glia to neuron ratio in the posterior aspect of the human spinal cord at thoracic segments relevant to spinal cord stimulation.

Amparo Ruiz-Sauri, Jorge M Orduña-Valls, Arantxa Blasco-Serra, Carlos Tornero-Tornero, David L Cedeño, Daniel Bejarano-Quisoboni, Alfonso A Valverde-Navarro, Ramsin Benyamin, Ricardo Vallejo

Open access · bronzeAbstract read
In one paragraph

Article in Journal of anatomy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Neuroprotective role of Noggin in spinal cord injury.Neural regeneration research · 2023
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2021
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Amparo Ruiz-SauriDepartment of Pathology, University of Valencia, Valencia, Spain.
Jorge M Orduña-VallsDepartment of Anesthesiology, Intensive Care, and Pain Management, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Arantxa Blasco-SerraDepartment of Human Anatomy and Embryology, University of Valencia, Valencia, Spain.ORCID 0000-0002-4040-3117
Carlos Tornero-TorneroDepartment of Anesthesiology, Intensive Care, and Pain Management, Hospital Clínico Universitario de Valencia, Valencia, Spain.
David L CedeñoBasic Science Research, Millennium Pain Center, Bloomington, IL, USA.
Daniel Bejarano-QuisoboniDepartment of Anesthesiology, Intensive Care, and Pain Management, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Alfonso A Valverde-NavarroDepartment of Human Anatomy and Embryology, University of Valencia, Valencia, Spain.ORCID 0000-0002-9681-2075
Ramsin BenyaminClínica Indolor, Valencia, Spain.
Ricardo VallejoClínica Indolor, Valencia, Spain.
Hospital Clínico Universitario de Valencia · ESIllinois Wesleyan University · USUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal cord stimulation (SCS) applied between T8 and T11 segments has been shown to be effective for the treatment of chronic pain of the lower back and limbs. However, the mechanism of the analgesic effect at these medullary levels remains unclear. Numerous studies relate glial cells with development and maintenance of chronic neuropathic pain. Glial cells are electrically excitable, which makes them a potential therapeutic target using SCS. The aim of this study is to report glia to neuron ratio in thoracic segments relevant to SCS, as well as to characterize the glia cell population at these levels. Dissections from gray and white matter of posterior spinal cord segments (T8, T9, intersection T9/T10, T10 and T11) were obtained from 11 human cadavers for histological analyses. Neuronal bodies and glial cells (microglia, astrocytes and oligodendrocytes) were immunostained, microphotographed and counted using image analysis software. Statistical analyses were carried out to establish significant differences of neuronal and glial populations among the selected segments, between the glial cells in a segment, and glial cells in white and gray matter. Results show that glia to neuron ratio in the posterior gray matter of the human spinal cord within the T8-T11 vertebral region is in the range 11 : 1 to 13 : 1, although not significantly different among vertebral segments. Glia cells are more abundant in gray matter than in white matter, whereas astrocytes and oligodendrocytes are more abundant than microglia (40 : 40 : 20). Interestingly, the population of oligodendrocytes in the T9/T10 intersection is significantly larger than in any other segment. In conclusion, glial cells are the predominant bodies in the posterior gray and white matter of the T8-T11 segments of the human spinal cord. Given the crucial role of glial cells in the development and maintenance of neuropathic pain, and their electrophysiological characteristics, anatomical determination of the ratio of different cell populations in spinal segments commonly exposed to SCS is fundamental to understand fully the biological effects observed with this therapy.

Indexed as

Spinal Cord StimulationAgedAged, 80 and overCell CountFemaleGray MatterHumansMaleMiddle AgedNeurogliaNeuronsSpinal CordThoracic VertebraeWhite Matteranatomyglial cellsneuronsspinal cord

Identifiers

PMID31347695
PMCPMC6794197
OpenAlexW2965419392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.